Skip to main content
Fig. 6 | Lipids in Health and Disease

Fig. 6

From: Apolipoprotein-A is a potential prognostic biomarker for severe aplastic anemia patients treated with ATG-based immunosuppressive therapy: a single-center retrospective study

Fig. 6

Overall survival (OS) and event free survival (EFS) based on serum IgA level. There was no significantly differences on EFS nor OS based on serum IgA level. The estimated 8.5-year EFS was 71.6% in group with IgA < 1.72 g/L and 62.0% in group with IgA ≥ 1.72 g/L; and the estimated 8.5-year OS was 83.1% and 84.8% in group with IgA < 1.72 g/L or ≥ 1.72 g/L,respectively

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X